Gutenberg Open Science: Search

Search

Results 1-10 of 22 (Search time: 0.006 seconds).

previous
1
2
3
next

Item hits:

Preview	Issue date	Online publication date	Title	Author(s)
	2018	17-Oct-2018	The immune contexture of hepatocellular carcinoma predicts clinical outcome	Foerster, Friedrich; Hess, Moritz; Gerhold-Ay, Aslihan; Marquardt, Jens; Becker, Diana; Galle, Peter R.; Schuppan, Detlef; Binder, Harald; Bockamp, Ernesto
	2018	17-Oct-2018	Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma	Mähringer-Kunz, Aline; Weinmann, Arndt; Schmidtmann, Irene; Koch, Sandra; Schotten, Sebastian; Pinto dos Santos, Daniel; Pitton, Michael B.; Düber, Christoph; Galle, Peter R.; Klöckner, Roman
	2019	11-Nov-2019	Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterol	Labenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
	2020	30-Jun-2020	Risk prediction in intrahepatic cholangiocarcinoma : direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC cancer staging system	Hahn, Felix; Müller, Lukas; Mähringer-Kunz, Aline; Schotten, Sebastian; Düber, Christoph; Hinrichs, Jan B.; Maschke, Sabine K.; Galle, Peter R.; Bartsch, Fabian; Lang, Hauke; Weinmann, Arndt; Kloeckner, Roman
	2020	16-Oct-2020	Risk stratification in advanced biliary tract cancer : validation of the A.L.A.N. score	Müller, Lukas; Mähringer-Kunz, Aline; Jungmann, Florian; Tanyildizi, Yasemin; Bartsch, Fabian; Czauderna, Carolin; Düber, Christoph; Galle, Peter R.; Weinmann, Arndt; Kloeckner, Roman; Hahn, Felix
	2021	30-Jun-2022	Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B	Sprinzl, Martin F.; Feist, Christina; Koch, Sandra; Kremer, Wolfgang Maximilian; Lackner, Karl J.; Weinmann, Arndt; Galle, Peter R.
	2021	7-Sep-2022	Ramucirumab in patients with previously treated advanced hepatocellular carcinoma : impact of liver disease aetiology	Galle, Peter R.; Kudo, Masatoshi; Llovet, Josep M.; Finn, Richard S.; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D.; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C.; Zhu, Andrew X.
	2021	12-Sep-2022	Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19	Hollerbach, Anne; Müller-Calleja, Nadine; Pedrosa, Denise; Canisius, Antje; Sprinzl, Martin F.; Falter, Tanja; Rossmann, Heidi; Bodenstein, Marc; Werner, Christian; Sagoschen, Ingo; Münzel, Thomas; Schreiner, Oliver; Sivanathan, Visvakanth; Reuter, Michael; Niermann, Johannes; Galle, Peter R.; Teyton, Luc; Ruf, Wolfram; Lackner, Karl J.
	2022	1-Dec-2022	Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization	Müller, Lukas; Hahn, Felix; Mähringer-Kunz, Aline; Stoehr, Fabian; Gairing, Simon Johannes; Foerster, Friedrich; Weinmann, Arndt; Galle, Peter R.; Mittler, Jens; Pinto dos Santos, Daniel; Pitton, Michael Bernhard; Düber, Christoph; Fehrenbach, Uli; Auer, Timo Alexander; Gebauer, Bernhard; Kloeckner, Roman
	2022	6-Dec-2022	Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19 : a prospective single-centre study	Kremer, Wolfgang M.; Labenz, Christian; Kuchen, Robert; Sagoschen, Ingo; Bodenstein, Marc; Schreiner, Oliver; Wörns, Marcus-Alexander; Sivanathan, Visvakanth; Weinmann, Arndt; Galle, Peter R.; Sprinzi, Martin F.